Haptena Therapeutics
haptena.com
Actively hiring
Biotechnology
Cell & Gene Therapy
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Claris Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Claris Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune…
Next generation immunotherapies for hard-to-treat cancers that are allogeneic and switchable.
Lever Bio aims to translate groundbreaking discoveries in immuno-oncology into next-generation cancer immunotherapies.
PINPOINT DNA MEDICINES FOR CHRONIC DISEASES. Next generation precision molecular therapies to tackle, in a safe and durable way, chronic…
Creating next generation immunotherapy treatments for cancer and autoimmune disease.
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
News
Haptena launches with €3 million seed financing from Claris Ventures to develop innovative treatments for KRAS-driven cancers
Haptena Therapeutics launches with a €3M seed round led by Claris Ventures to advance new treatments for KRAS-driven cancers. Founded by Chiara Ambrogio and Roberto Chiarle, the company aims to enhance precision oncology by targeting resistance mechanisms
Read more
Report